174 related articles for article (PubMed ID: 20044247)
1. The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy?
Courrech Staal EF; Wouters MW; van Sandick JW; Takkenberg MM; Smit VT; Junggeburt JM; Spitzer-Naaykens JM; Karsten T; Hartgrink HH; Mesker WE; Tollenaar RA
Eur J Cancer; 2010 Mar; 46(4):720-8. PubMed ID: 20044247
[TBL] [Abstract][Full Text] [Related]
2. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
3. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction.
Lagarde SM; Reitsma JB; de Castro SM; Ten Kate FJ; Busch OR; van Lanschot JJ
Br J Surg; 2007 Nov; 94(11):1361-8. PubMed ID: 17582230
[TBL] [Abstract][Full Text] [Related]
4. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
[TBL] [Abstract][Full Text] [Related]
5. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens.
Thompson SK; Ruszkiewicz AR; Jamieson GG; Esterman A; Watson DI; Wijnhoven BP; Lamb PJ; Devitt PG
Ann Surg Oncol; 2008 Dec; 15(12):3447-58. PubMed ID: 18830669
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of tumour-stroma ratio in triple-negative breast cancer.
Moorman AM; Vink R; Heijmans HJ; van der Palen J; Kouwenhoven EA
Eur J Surg Oncol; 2012 Apr; 38(4):307-13. PubMed ID: 22264965
[TBL] [Abstract][Full Text] [Related]
7. The degree of circumferential tumour involvement as a prognostic factor in oesophageal cancer.
Sillah K; Pritchard SA; Watkins GR; McShane J; West CM; Page R; Welch IM
Eur J Cardiothorac Surg; 2009 Aug; 36(2):368-73. PubMed ID: 19318270
[TBL] [Abstract][Full Text] [Related]
8. Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer.
Zingg U; Montani M; Busch M; Metzger U; Went P; Oertli D
Eur J Surg Oncol; 2009 Jun; 35(6):593-9. PubMed ID: 19121916
[TBL] [Abstract][Full Text] [Related]
9. Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two-field mediastinal lymphadenectomy?
D'Journo XB; Doddoli C; Michelet P; Loundou A; Trousse D; Giudicelli R; Fuentes PA; Thomas PA
Eur J Cardiothorac Surg; 2005 Apr; 27(4):697-704. PubMed ID: 15784377
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer.
Osugi H; Takemura M; Takada N; Hirohashi K; Kinoshita H; Higashino M
Br J Surg; 2002 Jul; 89(7):909-13. PubMed ID: 12081742
[TBL] [Abstract][Full Text] [Related]
11. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma.
Wang K; Ma W; Wang J; Yu L; Zhang X; Wang Z; Tan B; Wang N; Bai B; Yang S; Liu H; Zhu S; Cheng Y
J Thorac Oncol; 2012 Sep; 7(9):1457-61. PubMed ID: 22843085
[TBL] [Abstract][Full Text] [Related]
12. Pathological determinants of survival in node-negative oesophageal cancer.
Khan OA; Alexiou C; Soomro I; Duffy JP; Morgan WE; Beggs FD
Br J Surg; 2004 Dec; 91(12):1586-91. PubMed ID: 15505868
[TBL] [Abstract][Full Text] [Related]
13. Changing patterns and surgical results in adenocarcinoma of the oesophagus.
Thomas P; Doddoli C; Lienne P; Morati N; Thirion X; Garbe L; Giudicelli R; Fuentes P
Br J Surg; 1997 Jan; 84(1):119-25. PubMed ID: 9043475
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies.
Courrech Staal EF; Smit VT; van Velthuysen ML; Spitzer-Naaykens JM; Wouters MW; Mesker WE; Tollenaar RA; van Sandick JW
Eur J Cancer; 2011 Feb; 47(3):375-82. PubMed ID: 21036599
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group.
Wijnhoven BP; Siersema PD; Hop WC; van Dekken H; Tilanus HW
Br J Surg; 1999 Apr; 86(4):529-35. PubMed ID: 10215831
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
[TBL] [Abstract][Full Text] [Related]
17. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer.
Fountoulakis A; Zafirellis KD; Dolan K; Dexter SP; Martin IG; Sue-Ling HM
Br J Surg; 2004 Aug; 91(8):997-1003. PubMed ID: 15286961
[TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
